ARTICLE | Clinical News
Introgen preclinical data
June 13, 2005 7:00 AM UTC
In a hamster model of cancer, INGN 007 significantly inhibited tumor growth and metastasis. INGN licensed the replicating adenovirus vector overexpressing ADP from VirRx Inc. (St. Louis, Mo.). Data we...